| infection and
inflammation |
| WBCs |
musculoskeletal infections
(e.g., osteomyelitis, spondylodiscitis, prosthetic joints, cardiovascular
implants) |
111In-oxine,
[99mTc]Tc-HMPAO, [18F]FDG |
numerous, see, e.g., refs (189, 311−313) |
| neutrophils |
chronic obstructive pulmonary
disease |
111In-oxine,
[99mTc]Tc-HMPAO, 111In-tropolone |
(314−318) |
| eosinophils |
asthma |
[99mTc]Tc-HMPAO |
(234, 241, 319) |
| |
|
|
|
| cardiovascular |
| RBCs |
transfusion recovery |
51Cr |
(320) |
| cardiac function |
99mTc |
(321) |
| cerebral
blood volume |
99mTc |
(322) |
| detection of bleeding |
99mTc, [18F]FDG |
(323−325) |
| platelets |
deep vein thrombosis, pulmonary
embolism |
111In-oxine,
[99mTc]Tc-HMPAO |
(326−329) |
| atherosclerosis |
111In-oxine |
(330) |
| |
|
|
|
| transplantation |
| hepatocytes |
liver diseases |
111In-oxine |
(331, 332) |
| mesenchymal stem cells |
cirrhosis |
111In-oxine |
(63) |
| peripheral
blood stem cells,
bone marrow stem cells |
myocardial infarction |
[18F]FDG, 111In-oxine |
(239, 240, 333, 334) |
| PBMCs |
graft rejection |
99mTc + SnCl2
|
(335) |
| WBCs |
graft rejection |
111In-oxine,
[99mTc]Tc-HMPAO |
(336) |
| |
|
|
|
| oncology |
| tumor-infiltrating lymphocytes |
metastatic melanoma |
111In-oxine |
(304, 337) |
| purified
antigen-specific T cells |
metastatic melanoma, breast
cancer |
111In-oxine |
(309, 310) |
| gammadelta (γδ) T cells |
melanoma, ovarian cancer,
colon cancer, adenocarcinoma, breast cancer, duodenal cancer, cervical
cancer, cholangiocarcinoma |
111In-oxine |
(338) |
| dendritic
cells |
multiple myeloma,
renal
cell carcinoma, cervical cancer, lung cancer, myosarcoma |
111In-oxine,
[18F]FDG, [64Cu]Cu-PTSM, [99mTc]Tc-HMPAO |
(58, 112, 188, 339) |
| macrophage activated killer
cells |
ovarian cancer |
111In-oxine,
[18F]FDG |
(187) |
